Search - tctmd.com

Displaying 641 - 660 of 1003

Sort: Relevancy | Date

Presentation TCT 2015

PLATFORM: Quality of Life and Economic Outcomes of An FFR-CT Diagnostic Strategy in Patients With Suspected Coronary Artery Disease

Presenter: Sunil V. Rao, Mark Andrew Hlatky

October 13, 2015

Presentation TCT 2015

TCT 38: Long-term Clinical Outcome of Resting Pd/Pa Versus FFR-Guided Deferral of Revascularization

Presenter: Javier Escaned, Johan HC Reiber, Gilbert Wijntjens

October 13, 2015

Presentation TCT 2015

TCT 36: Quantification of the Effect of Measurement Drift on the Diagnostic Performance of FFR, iFR, and Whole Cycle Pd/Pa

Presenter: Javier Escaned, Johan HC Reiber, Christopher Cook

October 13, 2015

Presentation TCT 2015

TCT 35: FFR Gray Zone and Clinical Outcome

Presenter: Javier Escaned, Johan HC Reiber, Julien Adjedj

October 13, 2015

Presentation TCT 2015

TCT 1: High Number of Angiographic Significant Lesions Are FFR Negative in STEMI Patients With Multivessel Disease Preliminary Insight Into the COMPARE-ACUTE Trial

Presenter: Eric Boersma, Richard Smalling, Pieter C. Smits

October 13, 2015

Presentation TCT 2015

PLATFORM: Quality-of-Life and Economic Outcomes of an FFR-CT Diagnostic Strategy in Patients With Suspected Coronary Artery Disease

Presenter: Mark Andrew Hlatky

October 13, 2015

Presentation TCT 2015

FFR and Changing Ad Hoc Cath Lab Decisions

Presenter: Daniel S. Berman, Pamela S. Douglas, Michael J. Lim

October 12, 2015

Presentation TCT 2015

FFR-CT: PLATFORM Results

Presenter: Daniel S. Berman, Pamela S. Douglas

October 12, 2015

Presentation TCT 2015

FFR-CT (Pre-PLATFORM data): A Paradigm Change?

Presenter: Daniel S. Berman, Pamela S. Douglas, James K. Min

October 12, 2015

Presentation TCT 2015

Advanced iFR: Lesion Assessment Using iFR/FFR Pullback

Presenter: Sergio B Baptista, Eric Van Belle, Justin E. Davies

October 12, 2015

Presentation TCT 2015

Left Main Disease: When to Use FFR vs IVUS

Presenter: Allen Jeremias, Nils Johnson, William F. Fearon

October 12, 2015

Presentation TCT 2015

The Ischemic Continuum: What Is the Significance of a Lower FFR?

Presenter: Justin E. Davies, Bernard De Bruyne, Nils Johnson

October 12, 2015

Presentation TCT 2015

CFR/FFR/IMR/HMR Discordance: Understanding the Differences

Presenter: Justin E. Davies, Bernard De Bruyne, Jan J. Piek

October 12, 2015

Presentation TCT 2015

Adenosine Variability and Other FFR Artifacts

Presenter: Justin E. Davies, Bernard De Bruyne, Morton J. Kern

October 12, 2015

Presentation TCT 2015

When Do I Use FFR vs iFR vs IMR vs CFR?

Presenter: Habib Samady, William F. Fearon

October 12, 2015

Presentation TCT 2015

Clinical Utility of CFR/IMR to Assess Microvasculature, Illustrated by Case Examples

Presenter: Habib Samady, Tim P. van de Hoef

October 12, 2015

Presentation TCT 2015

iFR and Pd/Pa to Guide PCI in Diffuse and Multivessel CAD: A Case-Based Review

Presenter: Habib Samady, Justin E. Davies

October 12, 2015

Presentation TCT 2015

FFR: Left Main, Serial Lesions, and ACS Cases

Presenter: Habib Samady

October 12, 2015

Presentation TCT 2015

PROMISE FFR-CT: Evaluation of FFR-CT in Patients Undergoing Computed Tomographic Angiography for Evaluation of Suspected Coronary Artery Disease

Presenter: Spencer B. King III, Jagat Narula, Michael Lu

October 12, 2015

Presentation TCT 2015

Optimal FFR Technique: Case-Based Review of Guide Selection, Hyperemia, Wire Manipulation, Artifacts, Grey Zones, and Tracing Interpretation

Presenter: Habib Samady, Nico H.J. Pijls

October 12, 2015

Advertisement

PLATFORM: Quality of Life and Economic Outcomes of An FFR-CT Diagnostic Strategy in Patients With Suspected Coronary Artery Disease

TCT 38: Long-term Clinical Outcome of Resting Pd/Pa Versus FFR-Guided Deferral of Revascularization

TCT 36: Quantification of the Effect of Measurement Drift on the Diagnostic Performance of FFR, iFR, and Whole Cycle Pd/Pa

TCT 35: FFR Gray Zone and Clinical Outcome

TCT 1: High Number of Angiographic Significant Lesions Are FFR Negative in STEMI Patients With Multivessel Disease Preliminary Insight Into the COMPARE-ACUTE Trial

PLATFORM: Quality-of-Life and Economic Outcomes of an FFR-CT Diagnostic Strategy in Patients With Suspected Coronary Artery Disease

FFR and Changing Ad Hoc Cath Lab Decisions

FFR-CT: PLATFORM Results

FFR-CT (Pre-PLATFORM data): A Paradigm Change?

Advanced iFR: Lesion Assessment Using iFR/FFR Pullback

Left Main Disease: When to Use FFR vs IVUS

The Ischemic Continuum: What Is the Significance of a Lower FFR?

CFR/FFR/IMR/HMR Discordance: Understanding the Differences

Adenosine Variability and Other FFR Artifacts

When Do I Use FFR vs iFR vs IMR vs CFR?

Clinical Utility of CFR/IMR to Assess Microvasculature, Illustrated by Case Examples

iFR and Pd/Pa to Guide PCI in Diffuse and Multivessel CAD: A Case-Based Review

FFR: Left Main, Serial Lesions, and ACS Cases

PROMISE FFR-CT: Evaluation of FFR-CT in Patients Undergoing Computed Tomographic Angiography for Evaluation of Suspected Coronary Artery Disease

Optimal FFR Technique: Case-Based Review of Guide Selection, Hyperemia, Wire Manipulation, Artifacts, Grey Zones, and Tracing Interpretation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content